Emergent BioSolutions ‘hopeful’ to return to vaccine production, plans to respond to FDA ‘within days’ - Washington Business Journal

On a first-quarter earnings call Thursday, Emergent's CEO addressed a turbulent month for the Gaithersburg biopharmaceutical company.

Image: https://www.bizjournals.com